Doctor Care Anywhere Group PLC · ASX:DOC
Doctor Care Anywhere — FY2022 Earnings Presentation
16 slides from Doctor Care Anywhere's earnings presentation, Feb 28, 2023
Slide 1: Doctor Care Anywhere FY22 Preliminary Results
For personal use only Doctor Care Anywhere Transforming lives through better healthcare FY22 Preliminary Results 28 February 2023 1 © 2023 Doctor Care Anywhere
Slide 2: Important Notice and Disclaimer
Important Notice and Disclaimer For personal use only This presentation is for information purposes only and it is not indicated. A number of figures, amounts, percentages, estimates, performance cannot be relied upon as a guide to future financial product or investment advice. The presentation is n
Slide 3: Executive Summary
Executive Summary For personal use only Company overview FY22 highlights • Doctor Care Anywhere is a UK leader 4o% increase • Gross margin improvement of more than 6ppt in FY22 in the provision of private virtual in consultations on to 42.9% healthcare • Underlying EBITDA losses reduced £2.9m in the
Slide 4: Strategic focus
Strategic focus For personal use only Renewed focus on Complete launch of Sustainable business core business target operating model Pathway to positive EBITDA and generating cash Primary focus on organic growth in core UK virtual driven by: • Efficient workforce utilisation to treat a wide business
Slide 5: Market pressures
Market pressures For personal use only UK market continues to experience unprecedented pressure • As of January 2023, routine GP appointment waiting times averaging 10 days1 • As of November, 40% of patients seeking a diagnostic test were being forced to wait more than four weeks, with 13% waiting f
Slide 6: Services overview
Services overview For personal use only Efficient workforce utilisation to treat a wide range of conditions at scale Patient Comes to DCA for healthcare need Key benefits Health Navigator Assigns patient to most appropriate treatment pathway For patients Faster access Better clinician outcomes For p
Slide 7: FY22 Results Overview
FY22 Results Overview For personal use only £29.8m 614,200 428,000 (A$52.3m) revenue consultations delivered consultations delivered 19% revenue growth on FY21 (+40% on FY21) to returning patients Driven by acquisition of 174,200 new patients Demonstrating quality and retention value of service 31,2
Slide 8: Key Metric Overview
Key Metric Overview For personal use only Consultations by quarter Revenue by quarter (£m’s) New patients Returning patients 70% Returning patient percentage FY22 Activated Lives by quarter (000’s) 8 © 2023 Doctor Care Anywhere
Slide 9: Profit and loss
Profit and loss For personal use only £ in millions FY22 FY21 Variance % 2H 22 1H 22 Variance % Utilisation revenue 27.6 21.0 6.6 31.3% 13.3 14.3 (0.9) (6.4%) Subscription revenue 2.2 1.9 0.3 13.6% 1.1 1.1 (0.1) (5.7%) Other revenue 0.0 2.0 (2.0) (99.7%) 0.0 0.0 0.0 2.0% Revenue 29.8 25.0 4.8 19.3%
Slide 10: FY22 financial performance analysis
FY22 financial performance analysis For personal use only Revenue growth in year Revenue for FY22 was £29.8 million (A$52.3 million), up 19.3% on FY21 • The main driver of revenue growth was the increase in GP consultations between the two periods (174,200 consult increase to 614,200 consults) Impro
Slide 11: FY23 financial performance analysis
FY23 financial performance analysis For personal use only 2H trend underlines effectiveness of cost cutting measures in year, with cost cutting measures continuing to be a focus in FY23 £m 2H22 1H22 Non-operating costs 9.6 14.4 Less restructuring costs - (1.6) Add back Share based payments 1.4 (0.2)
Slide 12: Cash flow vs. EBITDA
Cash flow vs. EBITDA For personal use only - • Operating cash outflow has historically 1H 21 2H 21 1H 22 2H 22 tracked EBITDA on a half yearly basis -2,000 • 2H21: Increased cash burn as Company expanded and cost base grew faster than revenue -4,000 • 1H22: Cost base reduction offset by restructurin
Slide 13: Balance sheet
Balance sheet For personal use only £ in thousands FY22 FY21 Variance % Property, plant and equipment 1,220 1,894 (674) (35.6%) Intangible assets 9,131 10,985 (1,854) (16.9%) Interest in joint venture 1,966 2,112 (146) (6.9%) Total non-current assets 12,317 14,991 (2,673) (17.8%) Trade and other rec
Slide 14: Market guidance update
Market guidance update For personal use only • The Company achieved revenue of £29.8m in FY22 in line with its Aug 22 revenue guidance of £28-31m Metric FY23 guidance Aug-22 Guidance Annualised revenue run rate 1H23 end £42-46m £44-48m Gross margin 50-55% by 2H23 end 50-55% by 1H23 end Contribution
Slide 15: FY23 look ahead
FY23 look ahead For personal use only Loan facility secured • The recently secured £10.0m AXA loan facility will help the business fund 2023 plans and continue its journey towards break even EBITDA. We expect to comply with all terms of the loan facility, including maintaining a minimum cash balance
Slide 16: For personal use only
@ doctor care anywhere.